Open Your FREE Demat Account Now!

Decipher Labs Ltd. Share Price

NSE
BSE

BSE : 524752

Sector : Healthcare

N/A
indicator
1D
1M
3M
6M
1Y
5Y
empty graph

Day's Range

Low

₹

High

₹

Price Summary

Previous Close ₹5.45
Day's Range ₹5.40 - ₹5.45
Open ₹5.40
52 Week Range ₹04.81 - ₹10.99
Volume 150
Market Cap ₹0.00

Stocks Summary

Trade Value ( ₹ in Lacs) 0.01
Market Cap (₹ in Mn) 0.00
Dividend Yield(%) 0.00
Price/Earning (TTM) 0.00
TTM EPS (₹) -3.03
P/E Ratio 0.00
Book Value(₹) 0.30
PAT Margin (%) -22.47
Face Value (₹) 10.00
ROCE(%) -28.39

Financials

Particulars QTR FY (₹ in Millions) Annual FY (₹ in Millions)
Net sales 29.24 226.12
Expenses N/A N/A
PBT -34.22 -63.86
Operating profit 0.0 0.0
Net profit -34.27 -50.8

Shareholding Pattern

Promoters (% Holding)

16.43%

Mutual funds (% Holding)

0.00%

Non-Institution (% Holding)

83.57%

FI/Banks/Insurance (% Holding)

0.00%

Government (% Holding)

0.00%

FII

0.00%

About Decipher Labs Ltd.

Founded 1986

Peer Comparision

Stocks Name Market Cap (Cr)(₹) Market Price (₹) 52 Week Low-High (₹)
Sun Pharmaceutical Industries Ltd. 4,25,150.16 1,793.55 1,583.70 - 1,583.70
Divi's Laboratories Ltd. 2,66,264.99 10,042.00 5,647.50 - 5,647.50
Torrent Pharmaceuticals Ltd. 1,76,300.50 4,670.00 3,532.60 - 3,532.60
Laurus Labs Ltd. 1,25,352.43 2,330.00 917.95 - 917.95
Zydus Lifesciences Ltd. 1,23,590.72 1,259.40 835.50 - 835.50
Apollo Hospitals Enterprise Ltd. 1,21,411.76 8,511.00 6,696.50 - 6,696.50
Lenskart Solutions Ltd. 1,16,724.84 683.05 0.00 - 0.00
Dr. Reddy's Laboratories Ltd. 1,14,351.20 1,361.60 1,101.00 - 1,101.00
Cipla Ltd. 1,12,474.18 1,397.30 1,165.70 - 1,165.70
Mankind Pharma Ltd. 1,02,315.40 2,487.90 1,909.70 - 1,909.70
no-content No Records Found

Latest News

Sep
29
2026
EQUITY Posted on Sep 29th 2026

Decipher Labs informs about closure of trading window

Pursuant to the Code of Conduct for Prevention of Insider Trading adopted by the Company under SEBI (Prohibition of Insider Trading) Regulations, 2015, Decipher Labs has informed that the trading window for dealing in the securities of the Company will remain closed from 01.10.2026 till 48 hours after the declaration of un audited financial results for the quarter and half year ending 30.09.2026, for all designated persons, their immediate relatives and all connected persons covered under the Company’s Code of Conduct. The same has been intimated to all the directors, officers and designated employees of the Company. Further the date of Board Meeting for the declaration of financial results of the Company for the quarter and half year ending 30.09.2026 will be intimated in due course.

The above information is a part of company’s filings submitted to BSE. 
Read More
Nov
4
2026
COMPANY Posted on Nov 4th 2026

Hikal - Quaterly Results

The sales for the September 2026 quarter moved up 36.33% to Rs. 4342.00 millions as compared to Rs. 3185.00 millions during the corresponding quarter last year.The Net Loss for the quarter ended September 2026 is Rs. -62.00 millions as compared to Net Loss of Rs. -347.00 millions of corresponding quarter ended September 2025Operating profit for the quarter ended September 2026 rose to 465.00 millions as compared to 93.00 millions of corresponding quarter ended September 2025.
(Rs. in Million)
  Quarter ended Year to Date Year ended
  202609 202509 % Var 202609 202509 % Var 202603 202503 % Var
Sales 4342.00 3185.00 36.33 8370.00 6989.00 19.76 17126.00 18598.00 -7.91
Other Income 17.00 19.00 -10.53 35.00 29.00 20.69 123.00 50.00 146.00
PBIDT 465.00 93.00 400.00 852.00 351.00 142.74 2328.00 3335.00 -30.19
Interest 134.00 149.00 -10.07 283.00 320.00 -11.56 621.00 752.00 -17.42
PBDT 331.00 -56.00 -691.07 658.00 31.00 2022.58 856.00 2583.00 -66.86
Depreciation 417.00 412.00 1.21 844.00 806.00 4.71 1638.00 1344.00 21.88
PBT -86.00 -468.00 -81.62 -186.00 -775.00 -76.00 -782.00 1239.00 -163.12
TAX -24.00 -121.00 -80.17 -49.00 -201.00 -75.62 -295.00 330.00 -189.39
Deferred Tax -24.00 -121.00 -80.17 -49.00 -201.00 -75.62 -275.00 30.00 -1016.67
PAT -62.00 -347.00 -82.13 -137.00 -574.00 -76.13 -487.00 909.00 -153.58
Equity 247.00 247.00 0.00 247.00 247.00 0.00 247.00 247.00 0.00
PBIDTM(%) 10.71 2.92 266.77 10.18 5.02 102.68 13.59 17.93 -24.19
Read More
Nov
4
2026
COMPANY Posted on Nov 4th 2026

Fortis MalarHospital - Quaterly Results

The revenue for the September 2026 quarter is pegged at Rs. 0.00 millions against Rs. 0.00 millions recorded during the year-ago period.The Net Profit of the company vaulted to 570.00% to Rs. 1.34  millions from Rs. 0.20 millions in the previous quarter.The company reported a good operating profit of 1.65 millions compared to 1.50 millions of corresponding previous quarter.
(Rs. in Million)
  Quarter ended Year to Date Year ended
  202609 202509 % Var 202609 202509 % Var 202603 202503 % Var
Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Income 5.56 5.17 7.54 10.91 51.24 -78.71 63.02 27.17 131.95
PBIDT 1.65 1.50 10.00 3.89 44.59 -91.28 47.91 5.95 705.21
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.10 0.00
PBDT 1.65 1.50 10.00 3.89 44.59 -91.28 47.91 5.85 718.97
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBT 1.65 1.50 10.00 3.89 44.59 -91.28 47.91 5.85 718.97
TAX 0.31 1.30 -76.15 0.78 2.62 -70.23 5.89 1.76 234.66
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 1.34 0.20 570.00 3.11 41.97 -92.59 42.02 4.09 927.38
Equity 187.57 187.57 0.00 187.57 187.57 0.00 187.57 187.57 0.00
PBIDTM(%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Read More
Nov
4
2026
COMPANY Posted on Nov 4th 2026

Yatharth Hospital - Quaterly Results

The Sales for the quarter ended September 2026 of Rs. 1949.06 millions rose by 40.86% from Rs. 1383.72 millions.Handsome Net Profit growth of 79.55% reported above the corresponding previous quarter figure of Rs. 370.61 millions to Rs. 206.41 millions.OP of the company witnessed a marginal growth to 605.02 millions from 331.00 millions in the same quarter last year.
(Rs. in Million)
  Quarter ended Year to Date Year ended
  202609 202509 % Var 202609 202509 % Var 202603 202503 % Var
Sales 1949.06 1383.72 40.86 3712.14 2690.94 37.95 5918.84 4564.84 29.66
Other Income 146.45 50.65 189.14 279.75 117.46 138.17 232.10 94.49 145.63
PBIDT 605.02 331.00 82.79 1139.89 754.13 51.15 1633.74 1387.10 17.78
Interest 58.03 1.85 3036.76 111.16 3.42 3150.29 57.31 6.16 830.36
PBDT 546.99 329.15 66.18 1028.73 750.71 37.03 1576.43 1380.94 14.16
Depreciation 105.62 63.18 67.17 206.51 110.05 87.65 304.59 186.63 63.21
PBT 441.37 265.97 65.95 822.22 640.66 28.34 1271.84 1194.31 6.49
TAX 70.76 59.56 18.80 169.93 163.03 4.23 317.74 317.39 0.11
Deferred Tax -28.26 3.47 -914.41 -16.43 5.29 -410.59 13.58 2.69 404.83
PAT 370.61 206.41 79.55 652.29 477.63 36.57 954.10 876.92 8.80
Equity 963.54 963.54 0.00 963.54 963.54 0.00 963.54 963.54 0.00
PBIDTM(%) 31.04 23.92 29.77 30.71 28.02 9.57 27.60 30.39 -9.16
Read More
Nov
4
2026
COMPANY Posted on Nov 4th 2026

Global Health - Quaterly Results

The sales surged to Rs. 12080.94 millions, up 30.40% for the September 2026 quarter as against Rs. 9264.28 millions during the corresponding quarter previous year.A good growth in profit of 29.29% reported to Rs. 1812.59  millions over Rs. 1401.99 millions of corresponding previous quarter.Operating profit surged to 3162.92 millions from the corresponding previous quarter of 2153.73 millions.
(Rs. in Million)
  Quarter ended Year to Date Year ended
  202609 202509 % Var 202609 202509 % Var 202603 202503 % Var
Sales 12080.94 9264.28 30.40 22868.17 18085.84 26.44 37093.78 32041.46 15.77
Other Income 258.89 228.00 13.55 499.49 459.39 8.73 1064.08 908.09 17.18
PBIDT 3162.92 2153.73 46.86 5698.96 4330.93 31.59 8612.69 8559.45 0.62
Interest 170.65 88.83 92.11 329.55 145.41 126.64 410.85 333.91 23.04
PBDT 2992.27 2224.75 34.50 5369.41 4541.29 18.24 8205.61 7726.58 6.20
Depreciation 561.51 374.28 50.02 1107.55 708.36 56.35 1709.07 1496.11 14.23
PBT 2430.76 1850.47 31.36 4261.86 3832.93 11.19 6496.54 6230.47 4.27
TAX 618.17 448.48 37.84 1076.20 911.30 18.10 1534.53 1615.19 -4.99
Deferred Tax 7.74 89.86 -91.39 -79.98 139.41 -157.37 222.11 -0.34 -65426.47
PAT 1812.59 1401.99 29.29 3185.66 2921.63 9.04 4962.01 4615.28 7.51
Equity 537.35 537.58 -0.04 537.54 537.58 -0.01 537.38 537.17 0.04
PBIDTM(%) 26.18 23.25 12.62 24.92 23.95 4.07 23.22 26.71 -13.08
Read More
no-content No Records Found

Sign in to Unlock Offers!

Explore Loans, Cards, Investments & Insurance

No SPAM We don't SPAM
Right Hand Side Image
STEP 1/2

Open Demat Account today!

+91

Enter mobile number

Invalid mobile number

Enter Full Name

Invalid Full Name

Verification required
close

Enter the One Time Password (OTP)

Sent to ********99

Edit Number
Enter valid OTP
Field should not be blank
You have exhausted your OTP attempts try again after 10 min

Request another in 60s

Resend OTP

secure   100% safe and secure

Frequently Asked Questions

What is the current share price of Decipher Labs Ltd. ?

The current share price of Decipher Labs Ltd. is ₹5.45 as of 2026-11-04.

The market capitalisation of Decipher Labs Ltd. is ₹5.45 as of 2026-11-03.

The 1-year return of Decipher Labs Ltd. is -4.28% as of 2025-11-03.

The P/E ratio of Decipher Labs Ltd. is 0.00 as of 2026-11-04.

The 52-week high and low of Decipher Labs Ltd. are ₹10.99 and ₹4.81, respectively, as of 2026-11-04.

The dividend yield of Decipher Labs Ltd. is 0.0% as of2026-11-03.

You can buy Decipher Labs Ltd. shares through a registered stockbroker or trading platform. Bajaj Markets partners with trusted brokers to help you open a demat account. This is the first step to trading, making it easier to invest in your desired shares.

The Managing Director of Decipher Labs Ltd. is .

When investing in a company’s stock, you may consider key factors such as its fundamentals, including financial health, historical performance, and growth potential. Assess the consistency of its performance, market conditions, and industry trends. Additionally, evaluate your own risk tolerance while reviewing aspects like quarterly earnings, management quality, and sector performance, for taking a well-informed decision.

You can track stock performance on online platforms through live market updates, historical charts, and news alerts. Regular analysis and stock alerts allow you to stay informed about significant price changes and events affecting the stock.

Common stock provides voting rights and the potential for dividends based on company performance, while in case of preferred stock, stockholders receive fixed dividends and have priority over common stockholders in asset distribution but generally lack voting rights.

Stock investments carry market risks, including price volatility, economic shifts, and sector-specific issues. Managing risk can involve diversifying your portfolio, setting stop-loss orders, and staying informed about market trends to make timely decisions.

Market capitalisation, or market cap, is the total value of a company’s outstanding shares and is calculated by multiplying the stock price by the total shares. It classifies companies as large-cap, mid-cap, or small-cap, reflecting their size, stability, and potential risk level in the stock market.

View More

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform. 

Invalid Mobile Number

Invalid Full Name

Home
Home
ONDC_Shopping
Shopping
Loan
Loan Offers
My Accounts
My Accounts
Explore
Explore